Disposition of radiolabeled BMS-204352 in rats and dogs
β Scribed by Rajesh Krishna; Ming Yao; Nuggehally R. Srinivas; Vinod Shah; Janice M. Pursley; Mark Arnold; Nimish N. Vachharajani
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 80 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0142-2782
- DOI
- 10.1002/bdd.292
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
BMS-204352 is a novel maxi-K channel opener that is being developed for the treatment for stroke. The current study was designed to evaluate the dose proportionality and pharmacokinetics of BMS-204352 in rats. In an open, parallel fashion, sixteen rats per gender received a single intraarterial dose
The pharmacokinetic profiles of naproxen in blood and synovial fluid (SF) following topical and i.v. bolus administration in dogs, and the local tissue disposition of the drug following topical and oral administration in rats, were investigated to assess the feasibility of topical delivery of naprox
## Abstract Pharmacokinetics of sulpiride enantiomers after intravenous administration of (Β±)β, (+)β, and (β)βsulpiride was examined in humans and rats. Pharmacokinetic profiles were similar in (+)β and (β)βenantiomers after intravenous administration of (Β±)βsulpiride. Metabolic inversion at a chir